Revascularization Strategies and Outcomes in Elderly Patients With Multivessel Coronary Disease

被引:7
|
作者
Posenau, J. Trevor
Wojdyla, Daniel M.
Shaw, Linda K.
Alexander, Karen P.
Ohman, E. Magnus
Patel, Manesh R.
Smith, Peter K.
Rao, Sunil V.
机构
[1] Washington Univ, Sch Med, Div Cardiovasc, St Louis, MO 63110 USA
[2] Duke Clin Res Inst, Durham, NC USA
[3] Duke Univ, Med Ctr, Div Cardiovasc & Thorac Surg, Durham, NC USA
来源
ANNALS OF THORACIC SURGERY | 2017年 / 104卷 / 01期
关键词
BYPASS SURGERY; INTERVENTION; AGE; STENTS;
D O I
10.1016/j.athoracsur.2016.10.053
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. Balancing risks and benefits of revascularization in elderly patients with multivessel coronary artery disease (CAD) is challenging. The appropriate revascularization strategy for elderly patients with multivessel CAD is unclear. Methods. We used the Duke Databank for Cardiovascular Disease to identify patients aged 75 years or more who had multivessel disease and treatment with percutaneous coronary intervention or coronary artery bypass graft surgery (CABG) within 30 days of the index catheterization between October 1, 2003, and June 30, 2013. The primary outcome was a composite of all-cause death, myocardial infarction, and coronary revascularization through latest follow-up. Associations between baremetal stents (BMS), drug-eluting stents (DES), CABG, and outcomes were determined using multivariable Cox proportional hazards modeling, adjusting for potential confounders with CABG as the reference. Comparisons between BMS and DES were done using BMS as the reference. Results. We identified 763 patients who met the criteria (BMS, n = 202; DES, n = 411; CABG, n = 150). The median age was 79 years (interquartile range, 76 to 82), and the median follow-up was 6.28 years. After adjustment, both BMS and DES were associated with a higher risk of the primary outcome. The BMS versus CAB Ghazard ratio was 1.58 (95% confidence interval: 1.15 to 2.19, p = 0.01). The DES versus CABG hazard ratio was 1.45 (95% confidence interval: 1.08 to 1.95, p = 0.01). The adjusted hazard ratio for DES versus BMS (0.92, 95% confidence interval: 0.71 to 1.19, p = 0.51) was not statistically significant. Conclusions. In this single-center analysis of 763 elderly patients with multivessel disease, CABG was associated with the best overall clinical outcomes, but was selected for a minority of patients. An adequately powered, randomized trial should be considered to define the best treatment strategy for this population. (C) 2017 by The Society of Thoracic Surgeons
引用
收藏
页码:107 / 115
页数:9
相关论文
共 50 条
  • [1] Revascularization Strategies for Multivessel Coronary Artery Disease in the Elderly Population
    Hess, Nicholas R.
    Kilic, Arman
    Wang, Yisi
    Yoon, Pyongsoo D.
    Navid, Forozan
    Sultan, Ibrahim
    Chu, Danny
    JOURNAL OF SURGICAL RESEARCH, 2022, 270 : 444 - 454
  • [2] Coronary Revascularization Strategies in Patients With Diabetes and Multivessel Coronary Artery Disease
    Marso, Steven P.
    McGuire, Darren K.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (12) : 1198 - 1201
  • [3] Revascularization Strategies and Survival in Patients With Multivessel Coronary Artery Disease
    Fink, Noam
    Nikolsky, Eugenia
    Assali, Abid
    Shapira, Oz
    Kassif, Yigal
    Barac, Yaron D.
    Finkelstein, Ariel
    Eitan, Amnon
    Danenberg, Haim
    Zahger, Doron
    Sahar, Gideon
    Atar, Shaul
    Raanani, Ehud
    Bolotin, Gil
    Goldenberg, Ilan
    Segev, Amit
    ANNALS OF THORACIC SURGERY, 2019, 107 (01): : 106 - 111
  • [4] Coronary revascularization strategies in patients with multivessel disease: is it all about diabetes?
    Buccheri, Sergio
    Capodanno, Davide
    CARDIOVASCULAR DIAGNOSIS AND THERAPY, 2017, 7 (03) : E1 - E3
  • [5] Outcomes of myocardial revascularization in patients with obesity and multivessel coronary artery disease
    Madiyeva, Maira I.
    Aripov, Marat A.
    Goncharov, Alexey Y.
    Zholdasbekova, Rakhima Y.
    EGYPTIAN HEART JOURNAL, 2024, 76 (01):
  • [6] Multivessel coronary artery disease: current revascularization strategies
    Patil, CV
    Nikolsky, E
    Boulos, M
    Grenadier, E
    Beyar, R
    EUROPEAN HEART JOURNAL, 2001, 22 (14) : 1183 - 1197
  • [7] Optimal revascularization strategies for multivessel coronary artery disease
    Daemen, Joost
    Serruys, Patrick W.
    CURRENT OPINION IN CARDIOLOGY, 2006, 21 (06) : 595 - 601
  • [8] Outcomes of Coronary Revascularization (Percutaneous or Bypass) in Patients With Diabetes Mellitus and Multivessel Coronary Disease
    Hee, Leia
    Mussap, Christian J.
    Yang, Lihua
    Dignan, Rebecca
    Kadappu, Krishna K.
    Juergens, Craig P.
    Thomas, Liza
    French, John K.
    AMERICAN JOURNAL OF CARDIOLOGY, 2012, 110 (05): : 643 - 648
  • [9] Revascularization Strategies for the Treatment of Multivessel Coronary Artery Disease in Patients With Diabetes Mellitus
    Tam, Derrick Y.
    Dharma, Christoffer
    Rocha, Rodolfo V.
    Austin, Peter C.
    Wijeysundera, Harindra C.
    Farkouh, Michael
    Gaudino, Mario
    Sadat, Sajad
    Lee, Douglas S.
    Fremes, Stephen E.
    CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2020, 13 (09) : E009082
  • [10] Acute Coronary Syndrome Revascularization Strategies With Multivessel Coronary Artery Disease
    Widmer, R. Jay
    Hammonds, Kendall
    Mixon, Timothy
    Exaire, Jose Emilio
    Chiles, Christopher Douglas
    Tavilla, Giuseppe
    Szerlip, Molly I.
    Dimaio, J. Michael
    AMERICAN JOURNAL OF CARDIOLOGY, 2024, 220 : 33 - 38